ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 372950 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 372950; 2) Community: the network communities that were significantly associated with the response to NSC 372950; 3) Molecule: the relationships between components within communities and NSC 372950; 4) MDR: the compounds that were significantly associated with the NSC 372950.

NSC Compound Enrichment Correlation
NSC 720174 Null 0.00707875925191925 -0.28381492
NSC 722222 Null 0.00707875925191925 0.035664338
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.00707875925191925 0.349701
NSC 736164 pyrazoline derivative 0.00707875925191925 0.36146454
NSC 742327 (3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone 0.00707875925191925 0.48108707
NSC 756304 GW678313X 0.00707875925191925 -0.33333632
NSC 756698 Clomiphene citrate (USAN) 0.00707875925191925 0.23491722
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.00707875925191925 0.27555973
NSC 380721 Eremantholide B 0.00744479268267742 0.3235836
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.00744479268267742 0.25670172
Total:169  Current:56    [First] [Prev] [Next] [Last]